Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0005783 | endoplasmic reticulum | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4H9J2
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 11 |
GO:0006644 | phospholipid metabolic process | 4 | 11 |
GO:0006793 | phosphorus metabolic process | 3 | 11 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0008610 | lipid biosynthetic process | 4 | 11 |
GO:0008654 | phospholipid biosynthetic process | 5 | 11 |
GO:0009058 | biosynthetic process | 2 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0019637 | organophosphate metabolic process | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044255 | cellular lipid metabolic process | 3 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090407 | organophosphate biosynthetic process | 4 | 11 |
GO:1901576 | organic substance biosynthetic process | 3 | 11 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 6 | 1 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 1 |
GO:0046337 | phosphatidylethanolamine metabolic process | 6 | 1 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 1 |
GO:0046486 | glycerolipid metabolic process | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004307 | ethanolaminephosphotransferase activity | 6 | 6 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 11 |
GO:0016780 | phosphotransferase activity, for other substituted phosphate groups | 4 | 11 |
GO:0017169 | CDP-alcohol phosphatidyltransferase activity | 5 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 129 | 133 | PF00656 | 0.440 |
CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.240 |
CLV_PCSK_KEX2_1 | 137 | 139 | PF00082 | 0.240 |
CLV_PCSK_SKI1_1 | 204 | 208 | PF00082 | 0.318 |
DEG_SCF_FBW7_1 | 10 | 17 | PF00400 | 0.592 |
DEG_SPOP_SBC_1 | 338 | 342 | PF00917 | 0.294 |
DOC_AGCK_PIF_2 | 29 | 34 | PF00069 | 0.533 |
DOC_CDC14_PxL_1 | 91 | 99 | PF14671 | 0.313 |
DOC_CKS1_1 | 11 | 16 | PF01111 | 0.642 |
DOC_CYCLIN_yClb1_LxF_4 | 294 | 300 | PF00134 | 0.289 |
DOC_MAPK_FxFP_2 | 327 | 330 | PF00069 | 0.311 |
DOC_MAPK_gen_1 | 253 | 263 | PF00069 | 0.334 |
DOC_MAPK_gen_1 | 280 | 289 | PF00069 | 0.445 |
DOC_MAPK_MEF2A_6 | 282 | 291 | PF00069 | 0.410 |
DOC_PP1_RVXF_1 | 273 | 280 | PF00149 | 0.253 |
DOC_PP4_FxxP_1 | 108 | 111 | PF00568 | 0.378 |
DOC_PP4_FxxP_1 | 327 | 330 | PF00568 | 0.311 |
DOC_USP7_MATH_1 | 14 | 18 | PF00917 | 0.581 |
DOC_USP7_MATH_1 | 226 | 230 | PF00917 | 0.408 |
DOC_USP7_MATH_1 | 315 | 319 | PF00917 | 0.417 |
DOC_USP7_MATH_1 | 338 | 342 | PF00917 | 0.294 |
DOC_WW_Pin1_4 | 10 | 15 | PF00397 | 0.536 |
DOC_WW_Pin1_4 | 100 | 105 | PF00397 | 0.342 |
DOC_WW_Pin1_4 | 107 | 112 | PF00397 | 0.331 |
DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.556 |
LIG_14-3-3_CanoR_1 | 204 | 209 | PF00244 | 0.489 |
LIG_14-3-3_CanoR_1 | 275 | 280 | PF00244 | 0.552 |
LIG_14-3-3_CanoR_1 | 355 | 361 | PF00244 | 0.533 |
LIG_APCC_ABBA_1 | 28 | 33 | PF00400 | 0.505 |
LIG_APCC_ABBA_1 | 303 | 308 | PF00400 | 0.406 |
LIG_BRCT_BRCA1_1 | 295 | 299 | PF00533 | 0.289 |
LIG_BRCT_BRCA1_1 | 54 | 58 | PF00533 | 0.196 |
LIG_Clathr_ClatBox_1 | 394 | 398 | PF01394 | 0.321 |
LIG_CSL_BTD_1 | 219 | 222 | PF09270 | 0.355 |
LIG_deltaCOP1_diTrp_1 | 235 | 242 | PF00928 | 0.237 |
LIG_FHA_1 | 101 | 107 | PF00498 | 0.401 |
LIG_FHA_1 | 11 | 17 | PF00498 | 0.612 |
LIG_FHA_1 | 140 | 146 | PF00498 | 0.446 |
LIG_FHA_1 | 155 | 161 | PF00498 | 0.393 |
LIG_FHA_1 | 228 | 234 | PF00498 | 0.374 |
LIG_FHA_1 | 357 | 363 | PF00498 | 0.539 |
LIG_FHA_2 | 205 | 211 | PF00498 | 0.525 |
LIG_LIR_Apic_2 | 250 | 254 | PF02991 | 0.233 |
LIG_LIR_Apic_2 | 3 | 7 | PF02991 | 0.630 |
LIG_LIR_Gen_1 | 25 | 34 | PF02991 | 0.576 |
LIG_LIR_Gen_1 | 296 | 305 | PF02991 | 0.238 |
LIG_LIR_Gen_1 | 55 | 64 | PF02991 | 0.248 |
LIG_LIR_Nem_3 | 218 | 224 | PF02991 | 0.287 |
LIG_LIR_Nem_3 | 246 | 251 | PF02991 | 0.370 |
LIG_LIR_Nem_3 | 25 | 29 | PF02991 | 0.551 |
LIG_LIR_Nem_3 | 259 | 265 | PF02991 | 0.218 |
LIG_LIR_Nem_3 | 272 | 277 | PF02991 | 0.310 |
LIG_LIR_Nem_3 | 278 | 284 | PF02991 | 0.494 |
LIG_LIR_Nem_3 | 296 | 302 | PF02991 | 0.190 |
LIG_LIR_Nem_3 | 328 | 332 | PF02991 | 0.240 |
LIG_LIR_Nem_3 | 55 | 61 | PF02991 | 0.233 |
LIG_LYPXL_yS_3 | 329 | 332 | PF13949 | 0.296 |
LIG_Pex14_2 | 54 | 58 | PF04695 | 0.435 |
LIG_PTB_Apo_2 | 393 | 400 | PF02174 | 0.331 |
LIG_SH2_CRK | 32 | 36 | PF00017 | 0.526 |
LIG_SH2_NCK_1 | 265 | 269 | PF00017 | 0.289 |
LIG_SH2_SRC | 148 | 151 | PF00017 | 0.440 |
LIG_SH2_SRC | 32 | 35 | PF00017 | 0.525 |
LIG_SH2_STAP1 | 32 | 36 | PF00017 | 0.503 |
LIG_SH2_STAT3 | 34 | 37 | PF00017 | 0.531 |
LIG_SH2_STAT5 | 125 | 128 | PF00017 | 0.301 |
LIG_SH2_STAT5 | 148 | 151 | PF00017 | 0.440 |
LIG_SH2_STAT5 | 251 | 254 | PF00017 | 0.327 |
LIG_SH2_STAT5 | 26 | 29 | PF00017 | 0.523 |
LIG_SH2_STAT5 | 262 | 265 | PF00017 | 0.248 |
LIG_SH2_STAT5 | 309 | 312 | PF00017 | 0.311 |
LIG_SH2_STAT5 | 322 | 325 | PF00017 | 0.305 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.526 |
LIG_SH3_3 | 101 | 107 | PF00018 | 0.317 |
LIG_SH3_3 | 355 | 361 | PF00018 | 0.535 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.566 |
LIG_SH3_3 | 83 | 89 | PF00018 | 0.416 |
LIG_SH3_5 | 30 | 34 | PF00018 | 0.534 |
LIG_SUMO_SIM_anti_2 | 112 | 117 | PF11976 | 0.391 |
LIG_SUMO_SIM_anti_2 | 59 | 66 | PF11976 | 0.308 |
LIG_SUMO_SIM_par_1 | 59 | 66 | PF11976 | 0.308 |
LIG_SUMO_SIM_par_1 | 95 | 101 | PF11976 | 0.281 |
LIG_TRFH_1 | 26 | 30 | PF08558 | 0.276 |
LIG_TRFH_1 | 322 | 326 | PF08558 | 0.419 |
MOD_CK1_1 | 158 | 164 | PF00069 | 0.276 |
MOD_CK1_1 | 244 | 250 | PF00069 | 0.493 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.449 |
MOD_CK2_1 | 204 | 210 | PF00069 | 0.324 |
MOD_GlcNHglycan | 142 | 145 | PF01048 | 0.196 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.467 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.602 |
MOD_GSK3_1 | 154 | 161 | PF00069 | 0.276 |
MOD_GSK3_1 | 243 | 250 | PF00069 | 0.429 |
MOD_GSK3_1 | 289 | 296 | PF00069 | 0.379 |
MOD_GSK3_1 | 333 | 340 | PF00069 | 0.294 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.363 |
MOD_N-GLC_1 | 244 | 249 | PF02516 | 0.354 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.451 |
MOD_NEK2_1 | 159 | 164 | PF00069 | 0.281 |
MOD_NEK2_1 | 168 | 173 | PF00069 | 0.268 |
MOD_NEK2_1 | 175 | 180 | PF00069 | 0.250 |
MOD_NEK2_1 | 188 | 193 | PF00069 | 0.319 |
MOD_NEK2_1 | 215 | 220 | PF00069 | 0.299 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.339 |
MOD_PIKK_1 | 401 | 407 | PF00454 | 0.431 |
MOD_PKA_1 | 140 | 146 | PF00069 | 0.276 |
MOD_PKA_1 | 401 | 407 | PF00069 | 0.431 |
MOD_Plk_1 | 244 | 250 | PF00069 | 0.426 |
MOD_Plk_4 | 109 | 115 | PF00069 | 0.293 |
MOD_Plk_4 | 155 | 161 | PF00069 | 0.241 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.365 |
MOD_Plk_4 | 183 | 189 | PF00069 | 0.373 |
MOD_Plk_4 | 215 | 221 | PF00069 | 0.330 |
MOD_Plk_4 | 247 | 253 | PF00069 | 0.495 |
MOD_Plk_4 | 269 | 275 | PF00069 | 0.311 |
MOD_Plk_4 | 293 | 299 | PF00069 | 0.267 |
MOD_Plk_4 | 340 | 346 | PF00069 | 0.277 |
MOD_Plk_4 | 39 | 45 | PF00069 | 0.415 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.303 |
MOD_Plk_4 | 53 | 59 | PF00069 | 0.214 |
MOD_Plk_4 | 81 | 87 | PF00069 | 0.530 |
MOD_ProDKin_1 | 10 | 16 | PF00069 | 0.406 |
MOD_ProDKin_1 | 100 | 106 | PF00069 | 0.418 |
MOD_ProDKin_1 | 107 | 113 | PF00069 | 0.330 |
MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.435 |
TRG_DiLeu_BaEn_2 | 194 | 200 | PF01217 | 0.316 |
TRG_ENDOCYTIC_2 | 26 | 29 | PF00928 | 0.411 |
TRG_ENDOCYTIC_2 | 32 | 35 | PF00928 | 0.336 |
TRG_ENDOCYTIC_2 | 329 | 332 | PF00928 | 0.291 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8V7 | Leptomonas seymouri | 62% | 94% |
A0A0S4J4C6 | Bodo saltans | 42% | 100% |
A0A1X0P7R6 | Trypanosomatidae | 47% | 98% |
A0A3Q8IJQ4 | Leishmania donovani | 78% | 100% |
A0A3R7N2B7 | Trypanosoma rangeli | 47% | 99% |
A4HXV5 | Leishmania infantum | 78% | 100% |
C9ZZU8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 100% |
E9ARL8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 77% | 100% |
Q4QDW1 | Leishmania major | 77% | 100% |